![Hubert Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hubert Chen
Chief Tech/Sci/R&D Officer at
VIKING THERAPEUTICS, INC.
Net worth: - $ as of 2026-07-30
Profile
Hubert C.
Chen is Chief Medical Officer at Viking Therapeutics, Inc. since 2026.
Former positions include President & Chief Scientific Officer at Forte Biosciences, Inc. from 2022 to 2024; Chief Medical Officer at Metacrine, Inc. from 2018 to 2021; Chief Medical & Scientific Officer at Pelican, Inc. from 2014 to 2018; Vice President-Clinical Development at Rein Therapeutics, Inc. from 2013 to 2014; Vice President-Translational Medicine at Regulus Therapeutics, Inc. from 2009 to 2012; Assistant Clinical Professor at The University of California, San Francisco from 2002 to 2012; Associate Director-Medical Sciences at Amgen, Inc. from 2004 to 2006; Senior Director-Clinical Research at Amylin Pharmaceuticals, Inc.; and Staff Research Investigator at The J.
David Gladstone Institutes.
Education includes a doctorate from The Trustees of Columbia University in The City of New York in 1995 and an undergraduate degree from Stanford University in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 0 ( -.--% ) | - $ | 2026-07-30 |
Hubert Chen active positions
| Companies | Position | Start |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2026-06-10 |
Former positions of Hubert Chen
| Companies | Position | End |
|---|---|---|
| FORTE BIOSCIENCES | President | 2024-03-14 |
| METACRINE, INC. | Chief Tech/Sci/R&D Officer | 2021-12-30 |
| PFENEX INC. | Chief Tech/Sci/R&D Officer | 2018-09-01 |
| REIN THERAPEUTICS INC. | Corporate Officer/Principal | 2014-09-30 |
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 2011-12-31 |
Training of Hubert Chen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
- Stock Market
- Insiders
- Hubert Chen
